Pharmaceutico-Analytical Study of Trivanga Bhasma and re-evaluation of its Clinical efficacy along with Nishamalaki Churna in the management of Madhumeha (Type II Diabetes) - NI

Institute Of Teaching and Research in Ayurveda, Jamnagar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1)Both the sexes having age between 30 to 60 years.
•2)Diagnosed case of Insulin Resistant Type II Diabetes.
•3)Patients having raised BSL or HbA1C, with or without among chief complaints of Madhumeha (Prabhuta- Avilamutrata, Pipasadhikya, Kshudhadhikya etc.)
•4)Known patient of Type II Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS.
•5)Patients having Fasting blood sugar level =126 mg/dl and =200 mg/dl and or PPBS level =200 mg/dl and =350 mg/dl.xxiii
•6)Patients on conventional (Allopathic) oral hypoglycemic agents with and without medications for management of diabetes unchanged(antidiabetic management protocol) over period of last 3 months.

•1)Age more than 60 and below 30 years.
•2)All patients of diabetes mellitus receiving insulin.
•3)Patients having Fasting blood sugar level less than 126 mg/dl and more than 200 mg/dl and or PPBS level less than 200 mg/dl and more than 350 mg/dl.
•4)Malignant and accelerated hypertensive.
•5)Patients having chronic complications of Diabetes Mellitus ,Microvascular: Nephropathy,Macrovascular: Coronary artery disease (Acute or recent MI), Acute Peripheral vascular disease & Acute Cerebro-vascular episode. And acute complications like Prameha Pidaka (non-healing wound), extensive Localized or systemic virulent infection, Diabetic ketoacidosis.Other chronic debilitating diseases like STD etc,HIV positive cases,Secondary Diabetes mellitus

发起方

Institute Of Teaching and Research in Ayurveda, Jamnagar